keyword
https://read.qxmd.com/read/38523193/-examining-the-link-between-tooth-agenesis-and-papillary-thyroid-cancer-is-there-a-risk-factor-observational-study
#21
JOURNAL ARTICLE
Željana Matošić, Luka Šimunović, Tomislav Jukić, Roko Granić, Senka Meštrović
BACKGROUND: Mutations in one or multiple genes can lead to hypodontia and its characteristic features. Numerous studies have shown a strong genetic influence on the occurrence of hypodontia, and identified several genes, including AXIN2, EDA, FGF3, FGFR2, FGFR10, WNT10A, MSX1, and PAX9, that are directly associated with dental agenesis and carcinogenesis. The objective of this study was to investigate the occurrence and pattern of tooth agenesis, microdontia, and palatally displaced canine (PDC) in women diagnosed with papillary thyroid cancer (PTC), compared to a control group of women without any malignancy or thyroid disease...
March 25, 2024: Progress in Orthodontics
https://read.qxmd.com/read/38513355/value-of-follow-up-diagnostic-radioiodine-scans-in-differentiated-thyroid-cancer
#22
JOURNAL ARTICLE
Teresa Kraus, Natalia Shengelia-de Lange, Holger Einspieler, Marcus Hacker, Alexander Haug, Elisabeth Kretschmer-Chott, Georgios Karanikas
BACKGROUND: The most important part of the follow-up of differentiated thyroid carcinoma (DTC) is the measurement of serum thyroglobulin (Tg). An increase of Tg levels indicates likely tumor recurrence. According to the guidelines of the European Society of Medical Oncology (ESMO) the follow-up should consist of serum Tg assays and a neck ultrasound, while the American Thyroid Association (ATA) recommends serum Tg assays, neck ultrasounds, and a diagnostic radioiodine Whole Body Scan (WBS) if non-stimulated Tg is greater than 10ng/mL or if Tg is rising...
March 1, 2024: Endocrine Connections
https://read.qxmd.com/read/38509965/identification-and-analysis-of-prognostic-metabolic-characteristics-in-colon-adenocarcinoma
#23
JOURNAL ARTICLE
Yang Yang, Xinyu Yang, Shiqi Ren, Yang Cao, Ziheng Wang, Zhouyang Cheng
Colon adenocarcinoma (COAD) is a highly lethal gastrointestinal malignancy. The five-year survival rate of metastatic colorectal cancer remains low, at 14 percent. Numerous publications have suggested a role for peroxisome proliferator-activated receptors (PPARs) in malignancy. Recent studies have shown that PPARs, as nuclear transcription factors, may serve as potential targets for the treatment of metabolic syndrome tumors and their associated complications. However, the molecular mechanism has not been thoroughly investigated...
March 30, 2024: Heliyon
https://read.qxmd.com/read/38500454/utility-of-30-day-mortality-as-a-quality-metric-for-palliative-radiation-treatment-a-population-based-analysis-from-queensland-australia
#24
JOURNAL ARTICLE
Tracey L Guan, Justin H Kutzko, Dominic P Lunn, Nathan Am Dunn, Bryan H Burmeister, Parvati Dadwal, Nancy Tran, Tanya R Holt
INTRODUCTION: Palliative radiotherapy (PRT) is frequently used to treat symptoms of advanced cancer, however benefits are questionable when life expectancy is limited. The 30-day mortality rate after PRT is a potential quality indicator, and results from a recent meta-analysis suggest a benchmark of 16% as an upper limit. In this population-based study from Queensland, Australia, we examined 30-day mortality rates following PRT and factors associated with decreased life expectancy. METHODS: Retrospective population data from Queensland Oncology Repository was used...
March 19, 2024: Journal of Medical Imaging and Radiation Oncology
https://read.qxmd.com/read/38477380/hypofractionated-radiation-therapy-combined-with-androgen-deprivation-therapy-for-high-risk-localized-prostate-cancer
#25
JOURNAL ARTICLE
Tae Hoon Lee, Hongryull Pyo, Gyu Sang Yoo, Seong Soo Jeon, Seong Il Seo, Byong Chang Jeong, Hwang Gyun Jeon, Hyun Hwan Sung, Minyong Kang, Wan Song, Jae Hoon Chung, Bong Kyung Bae, Won Park
INTRODUCTION: This study aimed to analyse the treatment outcomes of moderately hypofractionated radiation therapy (RT) combined with androgen deprivation therapy (ADT) and the prognostic implications of prostate-specific antigen (PSA) kinetics in high-risk localized prostate cancer. METHODS: The medical records of 140 patients who underwent definitive RT (70 Gy in 28 fractions) combined with ADT were retrospectively reviewed. ADT consists of a gonadotropin-releasing hormone agonist and an anti-androgen...
March 13, 2024: Journal of Medical Imaging and Radiation Oncology
https://read.qxmd.com/read/38471676/intraepithelial-tumor-infiltrating-lymphocytes-shape-loco-regional-pet-ct-spread-of-locally-advanced-cervical-cancer
#26
JOURNAL ARTICLE
Mathilde Del, Claire Illac, Mathilde Morisseau, Martina Aida Angeles, Anne Ducassou, Sarah Betrian, Guillaume Bataillon, Gwenael Ferron, Elodie Chantalat, Erwan Gabiache, Alejandra Martinez
BACKGROUND: Data suggest an association between positron emission tomography/CT (PET/CT) metabolic metrics and tumor microenvironment in several malignancies, and a potential role of PET/CT to monitor response to immunotherapy. OBJECTIVE: To evaluate the correlation between tumor loco-regional extension and tumor-infiltrating lymphocyte infiltration in locally advanced cervical cancer prior to concurrent chemo-radiotherapy.The secondary objective was to assess the association between tumor-infiltrating lymphocytes and PET/CT metabolic metrics...
March 12, 2024: International Journal of Gynecological Cancer
https://read.qxmd.com/read/38453361/promising-candidate-prognostic-biomarkers-in-18-f-fdg-pet-images-evaluation-in-independent-cohorts-of-non-small-cell-lung-cancer-patients
#27
JOURNAL ARTICLE
Narinée Hovhannisyan-Baghdasarian, Marie Luporsi, Nicolas Captier, Christophe Nioche, Vesna Cuplov, Erwin Woff, Nadia Hegarat, Alain Livartowski, Nicolas Girard, Irène Buvat, Fanny Orlhac
The normalized distances from the hot spot of radiotracer uptake (SUVmax ) to the tumor centroid (NHOC) and to the tumor perimeter (NHOP) have recently been suggested as novel PET features reflecting tumor aggressiveness. These biomarkers characterizing the shift of SUVmax toward the lesion edge during tumor progression have been shown to be prognostic factors in breast and non-small cell lung cancer (NSCLC) patients. We assessed the impact of imaging parameters on NHOC and NHOP, their complementarity to conventional PET features, and their prognostic value for advanced-NSCLC patients...
April 1, 2024: Journal of Nuclear Medicine
https://read.qxmd.com/read/38450953/thirty-day-mortality-after-palliative-radiotherapy-in-advanced-cancer-patients-optimizing-end-of-life-care-in-asia
#28
JOURNAL ARTICLE
Mi Sun Kim, Hyejung Cha, Sei Hwan You, Sunghyun Kim
INTRODUCTION: Evidence-based guidelines recommend hypofractionated palliative radiotherapy (PRT); nonetheless, many patients receive prolonged course of PRT. To identify patients with limited benefits from PRT in end-of-life care, we evaluated the pattern of PRT at an Asian institution and factors associated with 30-day mortality after PRT (30dM). METHODS: We retrospectively reviewed 228 patients who died after PRT in Yonsei Wonju Severance Christian hospital between October 2014 and March 2022...
March 7, 2024: Journal of Medical Imaging and Radiation Oncology
https://read.qxmd.com/read/38450897/long-term-outcomes-of-definitive-radiation-with-volumetric-modulated-arc-therapy-and-concurrent-chemotherapy-for-squamous-cell-carcinoma-of-the-anus-in-a-regional-australian-cancer-centre
#29
JOURNAL ARTICLE
Michael Ti Hsieh, Thomas Philip Shakespeare, Lauren Winkley, Daniel Goonetilleke, Shaun Zheng Liang Yap, Abdul Rahim Mohd Tahir
INTRODUCTION: Concurrent chemoradiotherapy is the standard of care in the curative intent treatment of squamous cell carcinoma (SCC) of the anus. Volumetric arc therapy (VMAT) is a highly conformal radiation therapy technique that has been implemented to reduce toxicity for these patients. However, there are few reports evaluating the long-term outcomes of VMAT. Thus, we evaluated the survival and toxicity outcomes of anal cancer patients treated in our regional cancer centre undergoing curative intent chemoradiotherapy using VMAT and following the Australian EviQ guidelines...
March 7, 2024: Journal of Medical Imaging and Radiation Oncology
https://read.qxmd.com/read/38438481/recurrent-ube3c-lrp5-translocations-in-head-and-neck-cancer-with-therapeutic-implications
#30
JOURNAL ARTICLE
Bhasker Dharavath, Ashwin Butle, Akshita Chaudhary, Ankita Pal, Sanket Desai, Aniket Chowdhury, Rahul Thorat, Pawan Upadhyay, Sudhir Nair, Amit Dutt
Head and neck cancer is a major cause of morbidity and mortality worldwide. The identification of genetic alterations in head and neck cancer may improve diagnosis and treatment outcomes. In this study, we report the identification and functional characterization of UBE3C-LRP5 translocation in head and neck cancer. Our whole transcriptome sequencing and RT-PCR analysis of 151 head and neck cancer tumor samples identified the LRP5-UBE3C and UBE3C-LRP5 fusion transcripts in 5.3% of patients of Indian origin (n = 151), and UBE3C-LRP5 fusion transcripts in 1...
March 4, 2024: NPJ Precision Oncology
https://read.qxmd.com/read/38429330/acetylcholinesterase-enzyme-among-cancer-patients-a-potential-diagnostic-and-prognostic-indicator-a-multicenter-case-control-study
#31
JOURNAL ARTICLE
Gasmelseed Y Ahmed, Ahmed A Osman, Ahlam Mukhtar
Acetylcholinesterase enzyme (AChE) activity is impaired by a variety of inhibitors including organophosphorus pesticides, leading to the accumulation of acetylcholine. In this study, we aimed to determine the association between cancer and the blood level of the (AChE). This is a multicenter hospital-based case-control study conducted in the Radiation and Isotopes Center Khartoum, and Institute of Nuclear Medicine and Molecular Biology and Oncology Gezira. One hundred and fifty participants, half of them cancer patients and half cancer free were recruited...
March 1, 2024: Scientific Reports
https://read.qxmd.com/read/38424680/tata-memorial-centre-evidence-based-use-of-nuclear-medicine-diagnostic-and-treatment-modalities-in-cancer
#32
JOURNAL ARTICLE
Ameya D Puranik, Sayak Choudhury, Suchismita Ghosh, Indraja D Dev, Varun Ramchandani, Abhishek Uppal, Vikrant Bhosale, Abhishek Palsapure, Rachita Rungta, Rakesh Pandey, Shweta Khatri, Gemson George, Yogesh Satamwar, Rahul Maske, Archi Agrawal, Sneha Shah, Nilendu C Purandare, Venkatesh Rangarajan
PET/CT and radioisotope therapy are diagnostic and therapeutic arms of Nuclear Medicine, respectively. With the emergence of better technology, PET/CT has become an accessible modality. Diagnostic tracers exploring disease-specific targets has led the clinicians to look beyond FDG PET. Moreover, with the emergence of theranostic pairs of radiopharmaceuticals, radioisotope therapy is gradually making it's way into treatment algorithm of common cancers in India. We therefore would like to discuss in detail the updates in PET/CT imaging and radionuclide therapy and generate a consensus-driven evidence based document which would guide the practitioners of Oncology...
January 1, 2024: Indian Journal of Cancer
https://read.qxmd.com/read/38423851/pet-ct-and-pet-mr-in-soft-tissue-sarcoma-an-update
#33
REVIEW
Hedieh Khalatbari, Barry L Shulkin, Marguerite T Parisi
Soft tissue sarcomas account for 6%-8% of pediatric cancers. The rhabdomyosarcoma family is the most frequent soft tissue sarcoma in this age group accounting for 3% of pediatric cancers. Rhabdomyosarcomas are high-grade tumors with a high propensity to metastasize. The risk-adapted, multimodal therapeutic approach for rhabdomyosarcomas incorporates a combination of surgery, radiotherapy, and multi-agent cytotoxic chemotherapy. Soft tissue sarcomas other than rhabdomyosarcoma account for 3%-4% of pediatric cancers...
February 28, 2024: Seminars in Nuclear Medicine
https://read.qxmd.com/read/38423627/current-status-of-prostate-specific-membrane-antigen-targeted-alpha-radioligand-therapy-in-prostate-cancer
#34
REVIEW
Gaku Yamamichi, Taigo Kato, Tadashi Watabe, Koji Hatano, Motohide Uemura, Norio Nonomura
Prostate cancer (PCa) is the most prevalent malignancy and leading cause of mortality in men. Despite the development of various drugs, such as novel androgen receptor signaling inhibitors and poly adenosine diphosphate-ribose polymerase inhibitors targeting homologous recombination repair-related genetic mutations, prognosis of metastatic castration-resistant prostate cancer remains unfavorable. However, recent advances in nuclear medicine have allowed for both imaging diagnostics and therapeutic interventions by targeting molecules specifically expressed in cancer cells with radioisotopes (RI)...
March 2024: Anticancer Research
https://read.qxmd.com/read/38395665/surveying-the-landscape-first-nations-m%C3%A3-tis-and-inuit-cancer-resources-in-radiation-therapy
#35
JOURNAL ARTICLE
Kari Osmar, Ashley Ayume, Tracey Lundstrom
INTRODUCTION/BACKGROUND: Alberta Health Services (AHS) is Canada's largest provincial integrated health care authority. AHS services over four million people with over 100,000 employees. In 2018, AHS introduced Indigenous training modules which were mandatory for all staff. These eight modules included topics detailing residential schools, Indian hospitals, The Indian Act, The 60's Scoop, Alberta's Indigenous populations, present day realities, including customs, practices and traditional medicines...
February 22, 2024: Journal of Medical Imaging and Radiation Sciences
https://read.qxmd.com/read/38388516/clinical-evaluation-of-deep-learning-for-tumor-delineation-on-18-f-fdg-pet-ct-of-head-and-neck-cancer
#36
JOURNAL ARTICLE
David G Kovacs, Claes N Ladefoged, Kim F Andersen, Jane M Brittain, Charlotte B Christensen, Danijela Dejanovic, Naja L Hansen, Annika Loft, Jørgen H Petersen, Michala Reichkendler, Flemming L Andersen, Barbara M Fischer
Artificial intelligence (AI) may decrease 18 F - FDG PET/CT-based gross tumor volume (GTV) delineation variability and automate tumor-volume-derived image biomarker extraction. Hence, we aimed to identify and evaluate promising state-of-the-art deep learning methods for head and neck cancer (HNC) PET GTV delineation. Methods: We trained and evaluated deep learning methods using retrospectively included scans of HNC patients referred for radiotherapy between January 2014 and December 2019 (ISRCTN16907234). We used 3 test datasets: an internal set to compare methods, another internal set to compare AI-to-expert variability and expert interobserver variability (IOV), and an external set to compare internal and external AI-to-expert variability...
February 22, 2024: Journal of Nuclear Medicine
https://read.qxmd.com/read/38377045/accuracy-of-mri-in-predicting-deep-myometrial-invasion-in-endometrial-cancer-and-the-influence-of-leiomyoma-adenomyosis-and-the-microcystic-elongated-and-fragmented-tumour-pattern
#37
JOURNAL ARTICLE
Anuja Liyanage, Supriya Cardoza, Darshna Kasabia, Helen Moore
INTRODUCTION: The most common form of endometrial cancer is Type 1 endometrioid adenocarcinoma. Depth of myometrial invasion is the most important prognostic factor correlating with overall patient survival. The objective was to investigate how accurate magnetic resonance imaging (MRI) is in predicting the depth of myometrial invasion in preoperative assessment, and the influence of leiomyoma and/or adenomyosis, or microcystic, elongated and fragmented (MELF) pattern of invasion on MRI diagnostic performance...
February 20, 2024: Journal of Medical Imaging and Radiation Oncology
https://read.qxmd.com/read/38365545/fibroblast-activation-protein-inhibitor-fapi-pet-imaging-in-sarcomas-a-new-frontier-in-nuclear-medicine
#38
REVIEW
Francesco Giammarile, Peter Knoll, Diana Paez, Enrique Estrada Lobato, Adriana K Calapaquí Terán, Roberto C Delgado Bolton
The field of nuclear medicine has witnessed significant advancements in recent years, particularly in the area of PET imaging. One such development is the use of Fibroblast Activation Protein Inhibitors (FAPI) as a novel radiotracer. FAPI PET imaging has shown promising results in various malignancies, including sarcomas, which are a diverse group of cancers originating from mesenchymal cells. This paper aims to explore the potential of FAPI PET imaging in the diagnosis, staging, and treatment monitoring of sarcomas...
February 15, 2024: Seminars in Nuclear Medicine
https://read.qxmd.com/read/38360049/need-for-objective-task-based-evaluation-of-image-segmentation-algorithms-for-quantitative-pet-a-study-with-acrin-6668-rtog-0235-multicenter-clinical-trial-data
#39
JOURNAL ARTICLE
Ziping Liu, Joyce C Mhlanga, Huitian Xia, Barry A Siegel, Abhinav K Jha
Reliable performance of PET segmentation algorithms on clinically relevant tasks is required for their clinical translation. However, these algorithms are typically evaluated using figures of merit (FoMs) that are not explicitly designed to correlate with clinical task performance. Such FoMs include the Dice similarity coefficient (DSC), the Jaccard similarity coefficient (JSC), and the Hausdorff distance (HD). The objective of this study was to investigate whether evaluating PET segmentation algorithms using these task-agnostic FoMs yields interpretations consistent with evaluation on clinically relevant quantitative tasks...
February 15, 2024: Journal of Nuclear Medicine
https://read.qxmd.com/read/38347830/myd88-signaling-pathways-role-in-breast-cancer
#40
REVIEW
Hongmei Zheng, Xinhong Wu, Liantao Guo, Jianhua Liu
MyD88 plays a central role in breast cancer, exerting a multitude of effects that carry substantial implications. Elevated MyD88 expression is closely associated with aggressive tumor characteristics, suggesting its potential as a valuable prognostic marker and therapeutic target. MyD88 exerts influence over several critical aspects of breast cancer, including metastasis, recurrence, drug resistance, and the regulation of cancer stem cell properties. Furthermore, MyD88 modulates the release of inflammatory and chemotactic factors, thereby shaping the tumor's immune microenvironment...
2024: Frontiers in Oncology
keyword
keyword
44408
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.